Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John D Scandling

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Kidney International|July 9, 2003
A randomized, placebo-controlled trial of IGF-1 for delayed graft function: a human model to study postischemic ARFMichelle A Hladunewich, Geraldine Corrigan, Geraldine C Derby, et al.
Clinical Transplantation|May 4, 2023
Pegloticase efficacy and safety in kidney transplant recipients; results of the phase IV, open-label PROTECT clinical trialAbdul Abdellatif, Lin Zhao, Jason Chamberlain, et al.
Clinical Transplantation|September 16, 2018
A new approach to kidney wait-list management in the kidney allocation system era: Pilot implementation and evaluationXingxing S Cheng, Stephan Busque, Jenny Lee, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 23, 2014
Correlates and outcomes of warfarin initiation in kidney transplant recipients newly diagnosed with atrial fibrillationColin R Lenihan, Maria E Montez-Rath, Jenny I Shen, et al.
Kidney360|April 4, 2022
SARS-CoV-2 Neutralizing Monoclonal Antibodies for the Treatment of COVID-19 in Kidney Transplant RecipientsAileen X Wang, Stephan Busque, Jamie Kuo, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 22, 2021
The organ procurement costs of expanding deceased donor organ acceptance criteria: Evidence from a cost function modelXingxing S Cheng, Philip J Held, Avi Dor, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 16, 2006
The role of pre-emptive re-transplant in graft and recipient outcomeAlexander S Goldfarb-Rumyantzev, John F Hurdle, Bradley C Baird, et al.
Clinical Transplantation|July 25, 2015
HCV infection is associated with lower survival in simultaneous liver kidney transplant recipients in the United StatesRyan B Perumpail, Robert J Wong, John D Scandling, et al.
Clinical Transplantation|April 28, 2006
Validation of a screening protocol for identifying low-risk candidates with type 1 diabetes mellitus for kidney with or without pancreas transplantationIrene W Y Ma, Hannah A Valantine, Atsuko Shibata, et al.
The New England Journal of Medicine|January 25, 2008
Tolerance and chimerism after renal and hematopoietic-cell transplantationJohn D Scandling, Stephan Busque, Sussan Dejbakhsh-Jones, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Kidney International|July 9, 2003
A randomized, placebo-controlled trial of IGF-1 for delayed graft function: a human model to study postischemic ARFMichelle A Hladunewich, Geraldine Corrigan, Geraldine C Derby, et al.
Clinical Transplantation|May 4, 2023
Pegloticase efficacy and safety in kidney transplant recipients; results of the phase IV, open-label PROTECT clinical trialAbdul Abdellatif, Lin Zhao, Jason Chamberlain, et al.
Clinical Transplantation|September 16, 2018
A new approach to kidney wait-list management in the kidney allocation system era: Pilot implementation and evaluationXingxing S Cheng, Stephan Busque, Jenny Lee, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 23, 2014
Correlates and outcomes of warfarin initiation in kidney transplant recipients newly diagnosed with atrial fibrillationColin R Lenihan, Maria E Montez-Rath, Jenny I Shen, et al.
Kidney360|April 4, 2022
SARS-CoV-2 Neutralizing Monoclonal Antibodies for the Treatment of COVID-19 in Kidney Transplant RecipientsAileen X Wang, Stephan Busque, Jamie Kuo, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 22, 2021
The organ procurement costs of expanding deceased donor organ acceptance criteria: Evidence from a cost function modelXingxing S Cheng, Philip J Held, Avi Dor, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 16, 2006
The role of pre-emptive re-transplant in graft and recipient outcomeAlexander S Goldfarb-Rumyantzev, John F Hurdle, Bradley C Baird, et al.
Clinical Transplantation|July 25, 2015
HCV infection is associated with lower survival in simultaneous liver kidney transplant recipients in the United StatesRyan B Perumpail, Robert J Wong, John D Scandling, et al.
Clinical Transplantation|April 28, 2006
Validation of a screening protocol for identifying low-risk candidates with type 1 diabetes mellitus for kidney with or without pancreas transplantationIrene W Y Ma, Hannah A Valantine, Atsuko Shibata, et al.
The New England Journal of Medicine|January 25, 2008
Tolerance and chimerism after renal and hematopoietic-cell transplantationJohn D Scandling, Stephan Busque, Sussan Dejbakhsh-Jones, et al.
Pageof 3